TRANSENDOTHELIAL TRANSPORT OF MODIFIED LOW-DENSITY LIPOPROTEINS

被引:0
作者
KIM, MJ
DAWES, J
JESSUP, W
机构
[1] HEART RES INST,CELL BIOL GRP,SYDNEY,NSW 2050,AUSTRALIA
[2] HEART RES INST,APPL RES GRP,SYDNEY,NSW 2050,AUSTRALIA
关键词
ENDOTHELIUM; LOW-DENSITY LIPOPROTEIN; TRANSPORT; OXIDATION; ATHEROSCLEROSIS;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Human umbilical vein endothelial cell monolayers were grown as monolayers on porous filters and their transcellular transport and degradation of I-125-labelled native and modified forms of LDL, supplied to either the intimal or the luminal face, were measured. Intact native, acetylated and oxidized LDL were all transported in both directions across the cell monolayers by receptor-independent mechanisms, and all forms of LDL were transported at similar rates. However, the mass of intact LDL transported from the intimal to the luminal face of the monolayer was always fourfold more than that transported in the opposite direction under similar conditions. In addition to LDL transport, endothelial cell monolayers also degraded native and modified forms of LDL by predominantly receptor-dependent routes, in that these could be inhibited (> 70%) by the addition of a 20-fold excess of the same form of (but unlabelled) LDL. The measured amounts of lipoprotein degraded were the same whether supplied to the intimal or the luminal face. Incubation of endothelial cells with oxidized LDL led to intracellular accumulation of a pool of macromolecular apo B which was apparently resistant to lysosomal proteolysis.
引用
收藏
页码:5 / 17
页数:13
相关论文
共 50 条
  • [41] Statin Effects on Both Low-Density Lipoproteins and High-Density Lipoproteins: Is There a Dual Benefit?
    Kiyoko Uno
    Stephen J. Nicholls
    [J]. Current Atherosclerosis Reports, 2010, 12 : 14 - 19
  • [42] Hyperlipidemia in tendon injury: chronicles of low-density lipoproteins
    Fang, William H.
    Bonavida, Victor
    Agrawal, Devendra K.
    Thankam, Finosh G.
    [J]. CELL AND TISSUE RESEARCH, 2023, 392 (02) : 431 - 442
  • [43] Antibodies against modified low-density lipoproteins and their complexes in blood of patients with various manifestations of atherosclerosis
    Belik I.V.
    Ivantsova A.A.
    Mamedova Z.E.
    Denisenko A.D.
    [J]. Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry, 2016, 10 (4) : 346 - 350
  • [44] Antigenic Differences between apo-B in Native and Circulating Modified Low-Density Lipoproteins
    I. V. Suprun
    A. A. Melnichenko
    E. V. Yanushevskaya
    T. N. Vlasik
    I. A. Sobenin
    O. M. Panasenko
    A. N. Orekhov
    [J]. Bulletin of Experimental Biology and Medicine, 2004, 138 : 42 - 44
  • [45] The possible origin of oxidized low-density lipoproteins in the circulation
    Itabe, H
    [J]. JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION, 2003, 34 (01) : 25 - 34
  • [47] STRUCTURAL AND FUNCTIONAL-PROPERTIES OF APOLIPOPROTEIN-B IN CHEMICALLY MODIFIED LOW-DENSITY LIPOPROTEINS
    VANDERYSE, L
    DEVREESE, AM
    BAERT, J
    VANLOO, B
    LINS, L
    RUYSSCHAERT, JM
    ROSSENEU, M
    [J]. ATHEROSCLEROSIS, 1992, 97 (2-3) : 187 - 199
  • [48] Adsorption kinetics of low-density lipoproteins with Langmuir monolayer
    Ziad Khattari
    [J]. Journal of Biological Physics, 2016, 42 : 539 - 550
  • [49] FRACTIONATION OF CHARGE-MODIFIED LOW-DENSITY LIPOPROTEINS BY FAST PROTEIN LIQUID-CHROMATOGRAPHY
    VEDIE, B
    MYARA, L
    PECH, MA
    MAZIERE, JC
    MAZIERE, C
    CAPRANI, A
    MOATTI, N
    [J]. JOURNAL OF LIPID RESEARCH, 1991, 32 (08) : 1359 - 1369
  • [50] The Influence of Adiponectin on Transport of Low-Density Lipoproteins through Human Endothelial Cell Monolayer In Vitro
    Tanyanskiy, D. A.
    Maltseva, O. N.
    Trulioff, A. S.
    Saginbaev, U. R.
    Evstigneeva, P. E.
    Voronkina, I. V.
    Smagina, L. V.
    Ivanova, A. A.
    Dmitrieva, A. A.
    Ageeva, E. V.
    Sall, T. S.
    Denisenko, A. D.
    [J]. BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2023, 176 (02) : 150 - 155